Esophageal Neoplasms: all 1,631 studies
Page 7 of 17. Open to participants first (469), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal CancerTerminatedNCT00573131Phase 2Results posted
- Phase II Trial for Patients With Loco-Regional Esophageal CarcinomaTerminatedNCT00570531Phase 2Results posted
- Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction CancerTerminatedNCT00551759Phase 2Results posted
- Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by SurgeryTerminatedNCT00539617Phase 2Results posted
- Bupropion in Helping Adults Stop SmokingCompletedNCT00534001Phase 2Results posted
- Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal CarcinomaCompletedNCT00525915Phase 2Results posted
- Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal CancerCompletedNCT00524121Phase 2Results posted
- Neoadjuvant Paclitaxel Poliglumex, Cisplatin and Radiation for Esophageal Cancer: A Phase II Trial (CTI#X64001)CompletedNCT00522795Phase 2Results posted
- Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction AdenocarcinomaCompletedNCT00515411Phase 2Results posted
- Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) TumorsCompletedNCT00515216Phase 2Results posted
- Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By SurgeryTerminatedNCT00493025Phase 2Results posted
- Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett EsophagusCompletedNCT00474903Phase 2Results posted
- Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal CancerCompletedNCT00470184Phase 2Results posted
- Combination Chemotherapy in Treating Patients With Previously Untreated Stage II or Stage III Esophageal Cancer That Can Be Removed By SurgeryCompletedNCT00448760Phase 2Results posted
- Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric AdenocarcinomaCompletedNCT00447330Phase 2Results posted
- Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal JunctionTerminatedNCT00442507Phase 2Results posted
- Cetuximab, Paclitaxel, Carboplatin & Radiation for Esoph, Gastroesoph & Gastric CancerCompletedNCT00439608Phase 2Results posted
- Preoperative Capecitabine, Oxaliplatin, Cetuximab, and Radiation Therapy for Locally Advanced Esophageal AdenocarcinomaTerminatedNCT00430027Not applicableResults posted
- Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED)TerminatedNCT00423150Phase 2Results posted
- Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and CisplatinCompletedNCT00397904Phase 2Results posted
- Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal CancerCompletedNCT00393068Phase 2Results posted
- Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal AdenocarcinomaCompletedNCT00390416Phase 2Results posted
- Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal CancerTerminatedNCT00387348Phase 3Results posted
- A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal CancerTerminatedNCT00383266Phase 2Results posted
- Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction CancerCompletedNCT00381706Phase 2Results posted
- Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit SmokingCompletedNCT00365508Phase 4Results posted
- A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's MetaplasiaCompletedNCT00357682Phase 3Results posted
- Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal CancerCompletedNCT00354679Phase 2Results posted
- Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By SurgeryCompletedNCT00316862Phase 2Results posted
- Radiation Therapy, Pemetrexed Disodium, and Carboplatin in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By SurgeryTerminatedNCT00268437Phase 2Results posted
- Gefitinib in Treating Patients With Recurrent or Metastatic Esophageal or Gastroesophageal Junction CancerCompletedNCT00268346Phase 2Results posted
- Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction CancerCompletedNCT00217581Phase 2Results posted
- Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus CancerCompletedNCT00193128Phase 1/2Results posted
- Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction CancerCompletedNCT00183898Phase 2Results posted
- Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT00183872Phase 2Results posted
- Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal CarcinomaCompletedNCT00176800Phase 2Results posted
- Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric CancerCompletedNCT00130689Phase 2Results posted
- S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal CancerTerminatedNCT00109850Phase 2Results posted
- S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction CancerCompletedNCT00096031Phase 2Results posted
- S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) JunctionCompletedNCT00086996Phase 2Results posted
- Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionCompletedNCT00069953Phase 2Results posted
- A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction CancerTerminatedNCT00064259Phase 1/2Results posted
- Esophagectomy in Treating Patients With High-Grade Dysplasia of the Esophagus or Stage I, Stage II, or Stage III Esophageal CancerCompletedNCT00063986Phase 2Results posted
- Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or StomachCompletedNCT00061932Phase 2Results posted
- Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal CancerCompletedNCT00052910Phase 3Results posted
- Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal CancerCompletedNCT00033657Phase 2Results posted
- Antineoplaston Therapy in Treating Patients With Cancer of the EsophagusTerminatedNCT00003487Phase 2Results posted
- The Clinical Application Value of CAIX-Targeted PET Hypoxia Imaging in Malignant TumorsActive, not recruitingNCT07890038
- Feasibility of Multi-cancer Early Detection Test in Screening Population (NQMD-CS)Active, not recruitingNCT07834268Not applicable
- Patient Priorities in the Management of Early Oesophageal Cancer: A Discrete Choice StudyCompletedNCT07828314
- Spatial MSC Index for Predicting Anti-PD-1 Efficacy in Esophageal CancerActive, not recruitingNCT07745322
- O-GlcNAcylation Induced HMGB1 SignallingActive, not recruitingNCT07702253
- Multimodal Al for Precision Diagnosis of Esophageal CancerTerminatedNCT07629921
- A Single-center, Single-arm Clinical Study Evaluating the Short-term Efficacy of Inflatable Mediastinoscopic-assisted Transhiatal Laparoscopic Esophagectomy for the Radical Resection of Thoracic Esophageal CancerCompletedNCT07581236Not applicable
- Comparison of Nab-Paclitaxel Versus Paclitaxel in Neoadjuvant Immunochemotherapy Therapy for Esophageal Squamous Cell Carcinoma: A Retrospective IPTW-Adjusted AnalysisCompletedNCT07549269
- Concentrated Complex Plant Dietary Elements for Chemotherapy-Induced DiarrheaCompletedNCT07460596Phase 2
- Local Treatment Strategies for Brain Metastases of Gastric and Esophageal CancerActive, not recruitingNCT07448493
- Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19CompletedNCT07416825Not applicable
- Shanghai Clinical Cohort - Esophageal CancerCompletedNCT07312526
- Sintilimab Combined With Chemotherapy Induction Therapy Followed by CCRT vs. CCRT for Esophageal Cancer: A Randomized Controlled Phase Ⅲ Clinical StudyActive, not recruitingNCT07306663Phase 3
- Longitudinal Geriatric Vulnerability, Chemotherapy Toxicity, and Functional Outcomes in Older Adults With Gastrointestinal CancerCompletedNCT07184047
- Perioperative Outcomes and Survival of Inflatable Video-Assisted Mediastinoscopic Transhiatal Esophagectomy for Selected Esophageal CancerCompletedNCT07182266
- High-flow Nasal Cannula Oxygenation in Sedated Endoscopy for High-risk Obstructive Sleep Apnea PatientsCompletedNCT07155330Not applicable
- Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic CancersActive, not recruitingNCT07118176Phase 1
- BURDEN OF ESOPHAGEAL CANCER IN EOSINOPHILIC ESOPHAGITIS (ESCAPE STUDY)CompletedNCT07102329
- INCIDENCE, PREVALENCE AND OVERALL RISK OF ESOPHAGEAL CANCER IN ACHALASIA: A PROPENSITY-MATCHED POPULATION-BASED STUDY FROM A LARGE MULTICENTER DATABASEActive, not recruitingNCT07022886
- Concurrent Radiotherapy Following Induction Chemoimmunotherapy for Locally Advanced Esophageal CancerCompletedNCT07015489Phase 2
- A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer PatientsActive, not recruitingNCT06960889
- Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in Peritoneal Metastatic Gastric/Gastroesophageal Junction AdenocarcinomaActive, not recruitingNCT06914687Phase 2
- Methylation Biomarkers for Pioneering Early Esophageal Cancer DetectionCompletedNCT06895551
- The Neoadjuvant Treatment Modalities in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma (NEO-EC）Active, not recruitingNCT06828718
- Combination COMBO Endoscopy Oropharyngeal Airway With High-Flow Nasal Cannula Oxygenation in Sedated Gastrointestinal Endoscopy for Obese PatientsCompletedNCT06812403Phase 2
- ProSight: A Multi-centre Interventional Study Evaluating MCED in Asymptomatic PopulationCompletedNCT06790355Not applicable
- Clinical Study on the Impact of Eradication of Oral Porphyromonas Gingivalis on the Prognosis of Early Esophageal Cancer After ESD SurgeryActive, not recruitingNCT06722300Not applicable
- Effect of Feeding Jejunostomy on Sarcopenia in Patients With Esophageal CancerActive, not recruitingNCT06712706
- A Study of PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 MutationTerminatedNCT06682806Phase 2
- A Multi-center, Two-arm, Phase 2 Clinical Study on the Perioperative Treatment of HER2-positive Resectable Esophagogastric Junctional Adenocarcinoma With Nabulimab Combined With FLOT and Trastuzumab VS FLOT Combined With TrastuzumabActive, not recruitingNCT06681298Phase 2
- Cola Ingestion for Esophageal Bolus ImpactionActive, not recruitingNCT06652620Not applicable
- Oncometabolome and MALDI-MSI in Upper GI Carcinomas - Chemosensitivity in Esophageal CarcinomaActive, not recruitingNCT06642506
- A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsActive, not recruitingNCT06607185Phase 1
- Enhanced Assistance During Radiotherapy for Unmet Essential NeedsCompletedNCT06582849Not applicable
- 18F-FSPG PET/CT as a Non-Invasive Imaging Biomarker for Treatment Response to Chemoradiation in Esophageal CancerTerminatedNCT06549413
- Retrospective Evaluation of Nivolumab in Adjuvant Esophageal Cancer/Gastroesophageal Junction CancerCompletedNCT06499298
- Defining Musical Toxicity and Its Effect on Patient Well-beingWithdrawnNCT06494046
- Temporal Variation in Exhaled Volatile Organic Compounds in Esophageal Cancer PatientsCompletedNCT06453993Not applicable
- PPIO-009 Tumor Regression Grade and Tumor Location in Esophageal CancerCompletedNCT06453395
- Efficacy and Safety of Neoadjuvant Nivolumab Plus SOX Versus Nivolumab Plus FLOT in Patients With HER2-negative Gastric and Gastroesophageal Junction AdenocarcinomaCompletedNCT06440811
- The Role of Surgery for Esophageal Cancer With Metastatic Disease (M1)CompletedNCT06424210
- A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal AdenocarcinomaCompletedNCT06381583
- A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid TumorsTerminatedNCT06336148Phase 1
- BEST-RPP Pilot: Screening for Esophageal Cancer in Rural Oregon Without an EndoscopyActive, not recruitingNCT06335966
- BReath Hold TecHniquEs for Radiotherapy of Esophageal CarcinomaTerminatedNCT06317272Not applicable
- Influence of Nutrition and Sarcopenia on Esophageal Cancer OutcomesCompletedNCT06314516
- Profiling Microbiome Associated Metabolic Pathways in Oesophageal Cancer SurvivorsActive, not recruitingNCT06302660
- An Exploratory Clinical Study to Evaluate the Safety and Efficacy of NK Cells (Combined With Standard Therapy) in the Treatment of Solid Tumor PatientsWithdrawnNCT06284226Early Phase 1
- Morbidity and Mortality After Esophageal and Esophagogastric Junction Cancer SurgeryCompletedNCT06277921
- The Effects of Acupressure on Improving Postoperative Gastrointestinal Symptom Distress in Esophageal Cancer PatientsCompletedNCT06275165Not applicable
- A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction CancerActive, not recruitingNCT06251973Phase 2
- A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid TumorsActive, not recruitingNCT06238479Phase 1
- A Study of the Tumor Microenvironment Affecting the Efficacy of Immunotherapy for Esophageal CancerCompletedNCT06219031